Neptune Wellness Solutions Inc.

OTC: NEPTF · Healthcare · Drug Manufacturers - Specialty & Generic

Canadian filerHQ Laval, QCCIK 0001401395Reports USD

#429 of 1,394 Healthcare companies by revenue54th-percentile growth

EA Score

——

FH —DQ 13GM —SS 42

v0.1 · 25/100 weight · pillars only

↑ listing tenure, revenue growth (YoY) · ↓ market scale, disclosure history

Methodology →

Revenue TTM

$39.1M

Rev growth YoY (TTM)

-26.5%

Net income (FY)

-$60.5M

Employees

Market cap

$453

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$51.7M$51.7M2023

Net income-$60.5M-$60.5M2023

Operating income-$102.8M-$102.8M2023

Total assets$30.9M$30.9M2023

Liabilities$58.5M$58.5M2023

Equity-$11.9M-$11.9M2023

Revenue trend

FY2022 – FY2023 · USD

$34.3M

FY22

$47.7M

FY22

$51.7M

FY23

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Neptune Wellness Solutions Inc. booked $51.7M in FY2023 revenue, growing 8.5% year over year — about the middle of the pack among Healthcare companies we track, at a -116.8% net margin.

Peers · Healthcare

Strategic Global Investments, Inc.——Core One Labs Inc.——Verde Science, Inc.——Cannabiz Mobile, Inc.——

Key facts

CEOMichael A. de Geus

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersLaval, QC

ExchangeOTC: NEPTF

Employees50

IPO date2007-08-13

Latest filings

8-K2024-05-06 8-K2024-04-12 8-K2024-03-27 8-K2024-03-12 8-K2024-03-06 8-K2024-02-27 8-K2024-02-20 10-Q2024-02-16

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.